Section 1013 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) authorizes research, demonstrations, and evaluations to improve the quality, effectiveness, and efficiency of the Federally-administered Medicare program and two programs for which funding and administration is shared with the States: Medicaid and the State Children's Health Insurance Program (SCHIP).
The U.S. Department of Health and Human Services invites suggestions from interested organizations and knowledgeable individuals regarding the highest priorities for research, demonstration, and evaluation projects to implement this section.
Recommendations for research that are made by the Centers for Medicare & Medicaid Services (CMS), the States, and other stakeholders will be reviewed and prioritized by a steering committee of the Department.
To participate in the process or learn more about Section 1013 of the MMA, go to: www.medicare.gov/MedicareReform/researchtopics.asp
Current as of May 2004
Internet Citation:
Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Section 1013: Suggest Priority Topics for Research. May 2004. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/about/mmarsrch.htm
Return to Events & Announcements
AHRQ Home Page
Department of Health and Human Services